| All | < 65 years | ≥65 years |
---|---|---|---|
n = 133 | n = 98 | n = 35 | |
Age at fracture (years) | 54 ± 18 (21–88) | 46 ± 14 (21–64) | 75 ± 6 (67–88) |
BMI (kg/m2) | 26.0 ± 3.8 (16.0–40.8) | 25.9 ± 3.8 (18.7–40.8) | 26.1 ± 3.7 (16.0–31.2) |
Charlson Comorbidity Index | 1 ± 1 (0–6) | 0 ± 1 (0–4) | 2 ± 2 (0–6) |
Smoking | |||
 - current | 22 (17%) | 21 (21%) | 1 (3%) |
 - former | 49 (37%) | 27 (28%) | 22 (63%) |
Medication for osteoporosisc | 6 (5%) | 2 (2%) | 4 (11%) |
Trauma level - low | 84 (63%) | 53 (54%) | 31 (89%) |
Dominant hand fracture | 51 (38%) | 35 (36%) | 16 (46%) |
Fracture classification AO | |||
 A | 35 (26%) | 21 (21%) | 14 (40%) |
 B | 13 (19%) | 12 (12%) | 1 (3%) |
 C | 76 (57%) | 57 (58%) | 19 (56%) |
Displacementb | |||
 Initial | 46 (39%) | 31 (35%) | 15 (50%) |
 Follow-up | 21 (23%) | 7 (8%) | 14 (41%) |
Treatment | |||
 Cast | 68 (51%) | 49 (50%) | 19 (54%) |
 Closed reduction & cast | 31 (23%) | 23 (23%) | 8 (23%) |
 Surgery | 34 (26%) | 26 (27%) | 8 (23%) |
BMD femoral neck (g/cm2) | 0.929 ± 0.14 (0.57–1.27) | 0.958 ± 0.14 (0.63–1.27) | 0.851 ± 0.12 (0.53–1.10) |
Osteoporosisa | 24 (18%) | 15 (15%) | 9 (26%) |
FRAXBMD (median, IQR)d | |||
 10-year risk of MOF | 6.6 (4.5;10) | 5.0 (3.9;9.4) | 8.8 (6.8;14.8) |
 10-year risk of Hip fracture | 1.6 (0.6;3.9) | 0.7 (0.4;1.7) | 3.6 (2;7.7) |